Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Interim Results

10 Sep 2012 07:00

RNS Number : 8476L
Steppe Cement Limited
10 September 2012
 



10 September 2012

 

Steppe Cement Ltd

Interim Results for the Half Year 30 June 2012

and General Market Update

 

1. Interim Results

Steppe Cement Ltd ("Steppe Cement" or the "Company") posted a consolidated loss after tax of USD0.1 million for the six months ended 30 June 2012.

 

6 months

ended

30 June 12

6 months

ended

30 June 11

% change

Sales (Tonnes)

615,838

601,099

2.5%

Consolidated turnover (USD Million)

52.2

43.0

21.4%

Consolidated loss after tax (USD Million)

(0.1)

(2.2)

Loss per share (Cents)

(0.1)

(1.3)

Average exchange rate (USD/KZT)

148

146

 

·; Sales increased by 23% in Tenge ("KZT") while volumes increased by 2%. The average sales price increased from USD72/tonne to USD86/tonne during the period.

·; Production costs per tonne increased by 11% in USD. The increase is due to higher electricity, transportation and coal costs partly offset by productivity increases. The number of employees declined from 1,049 to 1,036 as at the end of June 2012 despite the increase in production.

·; Selling expenses have grown on a per tonne basis by 19% mostly due to the increase in wagons rental rates.

·; General and administrative expenses increased by 15% during the period partly due to the organization of works for line 5.

·; Steppe Cement generated USD8.6 million cash from operations in the 1H 2012 while managing to maintain inventories that will allow us to increase sales significantly during the second half of 2012.

·; The KZT has slightly depreciated during the last 12 months and currently stands at about 149KZT to 1USD. 

·; The Kazakhstan economy is expected to grow at 5-6% in 2012.

 

 

2. Update on the Kazakh cement market

·; The Kazakhstan cement market increased by 16% during the first half of the year. Steppe Cement expects a market of 6.8 million tonnes for the full year 2012, an increase of 9.7% compared to the 6.2 million tonnes in 2011.

·; Prices are expected to increase in the 2H of 2012 when compared to the 1H of 2012.

·; Overall local production has increased by 20% in the first half of 2012 compared to 2011 while the share of the imported cement decreased from 17% to 14%.

·; Steppe Cement's market share decreased from 21% in 1H2011 to 19% in 1H2012 but Steppe Cement expects it to be around 20% for the full year 2012.

·; The Kazakhstan Government has continued its road building plan as well as significant infrastructure projects in the main cities.

·; There have been no new entrants in the market and the two factories that started in 2011 have ramped up capacity during the summer to cover increased demand.

3. Production and refurbishment progress

·; Dry line 6 production has increased by 24% when compared to last year while the wet lines production has decreased.

·; For the full year 2012 the volumes from the dry line are expected to reach 57% of total production.

·; The works on line 5 continue as we are taking advantage of the positive cash flows after fulfilling our financial obligations.

 

4. Financing

·; Steppe Cement continues to explore financing options from multilateral institutions as well as a potential bond issue in the local Kazakhstan Stock Market to finance the completion of line 5.

 

A pdf copy of the announcement and the full interim financial statements is available on the company's website at www.steppecement.com.

 

Steppe Cement's AIM nominated adviser is RFC Ambrian Limited.

Contact Stephen Allen or Trinity McIntyre at +61 8 94802500.

 

 

SUMMARY OF INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 30 JUNE 2012 (UNAUDITED)

(In United States Dollars)

 

The Notes to the Interim Financial Statements form an integral part of the Condensed Financial Statements. Please visit the Company's website at www.steppecement.com to view the full interim financial statements.

STEPPE CEMENT LTD

(Incorporated in Labuan FT, Malaysia under the Labuan Companies Act, 1990)

AND ITS SUBSIDIARY COMPANIES

 

CONDENSED CONSOLIDATED INCOME STATEMENT

FOR THE PERIOD ENDED 30 JUNE 2012 (UNAUDITED)

 

 

The Group

The Company

6 months ended

6 months ended

30 June 2012

30 June 2011

30 June 2012

30 June 2011

USD'000

USD'000

USD'000

USD'000

Revenue

52,155

43,059

50

50

Cost of sales

(34,099)

(30,757)

-

-

Gross profit

18,056

12,302

50

50

Selling expenses

(9,653)

(7,886)

-

-

General and administrative

expenses

(5,242)

(4,573)

(264)

(261)

Operating income/(loss)

3,161

(157)

(214)

(211)

Investment income

-

17

-

-

Finance costs

(2,268)

(2,673)

-

-

Other expense, net

(502)

(25)

(9)

(19)

Profit/(Loss) before income tax

391

(2,838)

(223)

(230)

Income tax (expense)/credit

(500)

600

-

-

Loss for the period

(109)

(2,238)

(223)

(230)

Attributable to:

Shareholders of the Company

(109)

(2,238)

(223)

(230)

Loss per share:

Basic (cents)

(0.1)

(1.3)

 

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE PERIOD ENDED 30 JUNE 2012 (UNAUDITED)

 

 

 

 

The Group

The Company

6 months ended

6 months ended

30 June 2012

30 June 2011

30 June 2012

30 June 2011

USD'000

USD'000

USD'000

USD'000

Loss for the period

(109)

(2,238)

(223)

(230)

Other comprehensive (loss)/income:

Exchange differences arising on translation of foreign subsidiary companies

(899)

1,357

-

-

Total comprehensive loss for the period

(1,008)

(881)

(223)

(230)

Attributable to:

Shareholders of the Company

(1,008)

(881)

(223)

(230)

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2012 (UNAUDITED)

 

 

The Group

The Company

Unaudited

Audited

Unaudited

Audited

30 June 2012

31 Dec 2011

30 June 2012

31 Dec 2011

USD'000

USD'000

USD'000

USD'000

Assets

Non-Current Assets:

Property, plant and equipment

130,743

134,761

-

-

Investment in subsidiary companies

-

-

26,500

26,500

Advances paid

906

993

-

-

Other assets

31,169

28,162

-

-

Total Non-Current Assets

162,818

163,916

26,500

26,500

Current Assets

Inventories, net

20,703

21,373

-

-

Trade receivables, net

5,303

2,582

-

-

Amount owing by subsidiary companies

-

-

28,939

29,151

Other receivables, advances and prepaid expenses

11,325

11,391

-

-

Cash and bank balances

8,322

494

159

103

Total Current Assets

45,653

35,840

29,098

29,254

Total Assets

208,471

199,756

55,598

55,754

 

The Group

The Company

Unaudited

Audited

Unaudited

Audited

30 June 2012

31 Dec 2011

30 June 2012

31 Dec 2011

USD'000

USD'000

USD'000

USD'000

Equity and Liabilities

Capital and Reserves

Share capital

58,298

58,298

58,298

58,298

Revaluation reserve

8,751

9,477

-

-

Translation reserve

(20,908)

(20,009)

-

-

Retained earnings/ (Accumulated loss)

79,838

79,221

(3,659)

(3,436)

Total Equity

125,979

126,987

54,639

54,862

Non-Current Liabilities

Loans

37,160

43,212

-

-

Deferred tax liabilities

6,617

6,176

-

-

Total Non-Current Liabilities

43,777

49,388

-

-

Current liabilities

Trade payables

6,481

7,841

-

-

Other payables and accrued liabilities

9,665

3,661

959

892

Loans

22,206

11,435

-

-

Taxes payable

363

444

-

-

Total Current Liabilities

38,715

23,381

959

892

Total Liabilities

82,492

72,769

959

892

Total Equity and Liabilities

208,471

199,756

55,598

55,754

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD ENDED 30 JUNE 2012 (UNAUDITED)

 

 

 

Non-distributable

Distributable

The Group

Share capital

Share Premium

Revaluation reserve

Translation reserve

Retained earnings

Total/Net

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

Balance as at 1 January 2011

58,298

-

10,940

(18,944)

74,425

124,719

Loss for the period

-

-

-

-

(2,238)

(2,238)

Exchange differences arising on translation of foreign subsidiary companies

-

-

-

1,357

-

1,357

Total comprehensive income/(loss) for the period

-

-

-

1,357

(2,238)

(881)

Balance as at 30 June 2011

58,298

-

10,940

(17,587)

72,187

123,838

 

 

 

Non-distributable

Distributable

 

The Group

Share capital

Share Premium

Revaluation reserve

Translation reserve

Retained earnings

Total/Net

 

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

 

Balance as at 1 January 2012

58,298

-

9,477

(20,009)

79,221

126,987

 

Loss for the period

-

-

-

-

(109)

(109)

 

Exchange differences arising on translation of foreign subsidiary companies

-

-

-

(899)

-

(899)

 

Total comprehensive loss for the period

-

-

-

(899)

(109)

(1,008)

 

Depreciation transfer on revaluation reserve

-

-

(726)

-

726

-

 

 

Balance as at 30 June 2012

58,298

-

8,751

(20,908)

79,838

125,979

 

 

 

 

Non-distributable

Distributable

The Company

Share capital

Share Premium

Retained earnings

Total/Net

USD'000

USD'000

USD'000

USD'000

Balance as at 1 January 2011

58,298

-

(3,038)

55,260

Total comprehensive loss for the period

-

-

(230)

(230)

Balance as at 30 June 2011

58,298

-

(3,268)

55,030

Balance as at 1 January 2012

58,298

-

(3,436)

54,862

Total comprehensive loss for the period

-

-

(223)

(223)

Balance as at 30 June 2012

58,298

-

(3,659)

54,639

 

 

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

FOR THE PERIOD ENDED 30 JUNE 2012 (UNAUDITED)

 

 

The Group

The Company

6 months ended

6 months ended

30 June 2012

30 June 2011

30 June 2012

30 June 2011

USD'000

USD'000

USD'000

USD'000

 

OPERATING ACTIVITIES

Profit/(Loss) before tax

391

(2,838)

(223)

(230)

Adjustments for non-cash items

7,612

6,621

7

-

Operating Profit/(Loss) Before Working Capital Changes

8,003

3,783

(216)

(230)

(Increase)/ Decrease in:

Inventories

2,038

1,411

-

-

Trade receivables

(2,720)

(414)

-

-

Other receivable and prepaid expenses

(1,124)

(1,399)

-

1

Amount owing by subsidiary companies

-

-

213

(350)

Increase/ (Decrease) in:

Trade payables

(1,421)

1,531

-

-

Other payables and accrued liabilities

6,135

4,840

59

106

Cash Generated From/(Used In) Operations

10,911

9,752

56

(473)

Income tax paid

(518)

(107)

-

-

Interest paid

(1,784)

(2,343)

-

-

Net Cash Generated From/(Used In) Operating Activities

8,609

7,302

56

(473)

INVESTING ACTIVITIES

Proceeds from disposal of property, plant and equipment

-

-

-

-

Purchase of property, plant and equipment

(1,755)

(280)

-

-

Purchase of non-current assets

(3,139)

(162)

-

-

Interest received

-

17

-

-

Net Cash Used In Investing Activities

(4,894)

(425)

-

-

FINANCING ACTIVITIES

Proceeds from borrowings

8,223

6,171

-

-

Repayment from borrowings

(4,107)

(2,910)

Net Cash From by Financing Activities

4,116

3,261

-

-

NET INCREASE/(DECREASE)/ IN CASH AND CASH EQUIVALENTS

7,831

10,138

56

(473)

EFFECTS OF FOREIGN EXCHANGE RATE CHANGES

(3)

85

-

-

CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD

494

9,532

103

964

CASH AND CASH EQUIVALENTS AT END OF THE PERIOD

8,322

19,755

159

491

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BKKDPBBKKFCD
Date   Source Headline
13th Jun 20197:00 amRNSFinal Dividend FY2018
13th Jun 20197:00 amRNSAGM Results
15th May 20197:00 amRNSAnnual Report 2018 and Notice of AGM
15th May 20197:00 amRNSCEO Statement 2018
23rd Apr 20197:00 amRNSHoldings in Company
10th Apr 20197:00 amRNSMarket update for the quarter ended 31 March 2019
4th Mar 20194:35 pmRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSHoldings in Company
10th Jan 20197:00 amRNSPreliminary Update for Year ended 31 December 2018
23rd Oct 20187:00 amRNSChange in Substantial Shareholders' Interests
8th Oct 20187:21 amRNSMarket Update for 3Q ended 30 September 2018
18th Sep 20187:00 amRNSInterim Results
13th Jul 20187:00 amRNSHolding(s) in Company
11th Jul 20187:00 amRNSMarket update for first half of 2018
25th Jun 20187:00 amRNSHolding(s) in Company
19th Jun 20187:00 amRNSDividend Announcement
15th Jun 20187:00 amRNSAGM Results
29th May 20187:00 amRNSAnnual Report 2017 and Notice of AGM
29th May 20187:00 amRNSResults and Annual Report 2017
12th Apr 20187:00 amRNSMarket update for the quarter ended 31 March 2018
15th Jan 20187:00 amRNSPreliminary Update for Year Ended 31 December 2017
8th Dec 20177:00 amRNSNew Significant Shareholder
17th Nov 20177:00 amRNSRepayment of Bonds
12th Oct 20177:00 amRNSAppointment of Independent Non-Executive Director
11th Oct 20177:00 amRNSMarket update for 3Q ended 30 September 2017
13th Sep 20177:00 amRNSInterim Results
15th Jun 20177:00 amRNSAGM Results
23rd May 20177:00 amRNSAnnual Report 2016
22nd May 20177:00 amRNSResults and Annual Report for 2016
13th Apr 20177:00 amRNSMarket update for March quarter
13th Jan 20177:00 amRNSPreliminary Update for Year Ended 31 December 2016
20th Dec 20167:00 amRNSHoldings in Company
29th Nov 20168:33 amRNSRefinancing and extension of loans
15th Nov 20167:00 amRNSPurchase of Shares by Substantial Shareholder
18th Oct 20167:00 amRNSHoldings in Company
12th Oct 20167:00 amRNSMarket Update for 3Q 2016
13th Sep 201612:39 pmRNSInterim Results - Correction
13th Sep 20167:00 amRNSInterim Results
8th Aug 20167:00 amRNSHoldings in Company
19th Jul 20168:23 amRNSHoldings in Company
14th Jul 20167:00 amRNSMarket update for the first half of 2016
10th Jun 20169:41 amRNSResult of AGM
26th May 20167:00 amRNSAnnual Report 2015
25th May 20167:00 amRNSResults and Annual Report for 2015
14th Apr 20167:00 amRNSMarket update for quarter to 31 March 2016
14th Jan 20167:00 amRNSPreliminary update to 31 December 2015
14th Dec 20157:00 amRNSChange in significant shareholding
26th Nov 20157:00 amRNSChange in substantial shareholding
13th Oct 20157:00 amRNSMarket Update for 3Q 2015
11th Sep 20157:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.